Richard Smeyne

Last updated

Richard Jay Smeyne is a neuroscientist who is currently Professor and Chair of the Department of Neuroscience at Thomas Jefferson University, where he is also Director of the Jefferson Comprehensive Parkinson's Disease and Movement Disorder Center at the Vickie and Jack Farber Institute for Neuroscience. [1] [2] [3] His research is focused on the cell biology of Parkinson's disease, as well as neuroprotection. [4]

He received his doctorate in neuroanatomy from Thomas Jefferson University in 1989, [5] and undertook postdoctoral training at the Roche Institute of Molecular Biology studying with Dr. Jim Morgan and Tom Curran. [1] As a postdoctoral fellow, Dr. Smeyne, along with colleagues in the Morgan and Curran lab were one of the first to generate a transgenic mouse that expressed the transgene under the control of its cognate promoter. In 1992, following his postdoctoral work, he started his own lab at the Bristol Myers Squibb Pharmaceutical Research Center in Princeton NJ. At BMS, he collaborated with the lab of Dr. Mariano Baarbacid to generate and analyze mice carrying mutations of the neurotrophin receptors TrkA, TrkB and TrkC. In 1994, Dr. Smeyne left BMS and was named the Head of the Neurogenetics Program in the Division of CNS Research at Hoffmann-La Roche. In 1996 following the closure of the Roche Institute of Molecular Biology, Dr. Smeyne was recruited to the faculty at Saint Jude Children's Research Hospital, where he joined, as an Associate Member rising to Full Member, in the Department of Developmental Neurobiology. [6] It was at SJCRH that Dr. Smeyne started his research program examining the cellular and molecular underpinnings of Parkinson's disease. In 2016, after 20 years at SJCRH, Dr. Smeyne was recruited to Thomas Jefferson University as a Full Professor and to be Head of the Comprehensive Parkinson's Disease Center. Under his leadership, the JCPDC was named a Center of Excellence by the Parkinson's Foundation. [7]

Dr. Smeyne has had a long-standing interest in the cell biology of Parkinson’s disease, with studies examining both environmental and genetic causation.  His lab was one the first to show, [8] in animal models of PD, that exercise could modify disease progression, and more recently has been examining the underlying molecular programs responsible for this neuroprotection . He is also recognized for his work examining interactions of the peripheral immune system with that of the brain’s innate immune system immune as well as the role of viruses in the etiology of Parkinson’s disease.  Currently, Dr. Smeyne serves as the Chair of the Clinical and Scientific Advisory Board for the Parkinson’s Foundation. [9] His lab is currently funded by the NIH, the Parkinson’s Disease Foundation, and the Michael J Fox Foundation for Parkinson’s Research

According to PubMed, Dr. Smeyne has published 113 papers. He was recently named by research.com to the list of top 1,000 neuroscientists in the USA. [10]

Related Research Articles

<span class="mw-page-title-main">Neuroscience</span> Scientific study of the nervous system

Neuroscience is the scientific study of the nervous system, its functions, and its disorders. It is a multidisciplinary science that combines physiology, anatomy, molecular biology, developmental biology, cytology, psychology, physics, computer science, chemistry, medicine, statistics, and mathematical modeling to understand the fundamental and emergent properties of neurons, glia and neural circuits. The understanding of the biological basis of learning, memory, behavior, perception, and consciousness has been described by Eric Kandel as the "epic challenge" of the biological sciences.

The following outline is provided as an overview of and topical guide to neuroscience:

<span class="mw-page-title-main">Neuroscientist</span> Individual who studies neuroscience

A neuroscientist is a scientist who has specialised knowledge in neuroscience, a branch of biology that deals with the physiology, biochemistry, psychology, anatomy and molecular biology of neurons, neural circuits, and glial cells and especially their behavioral, biological, and psychological aspect in health and disease.

<span class="mw-page-title-main">Neuroprotection</span> Relative preservation of neurons

Neuroprotection refers to the relative preservation of neuronal structure and/or function. In the case of an ongoing insult the relative preservation of neuronal integrity implies a reduction in the rate of neuronal loss over time, which can be expressed as a differential equation.

Michael Greenberg is an American neuroscientist who specializes in molecular neurobiology. He served as the Chair of the Department of Neurobiology at Harvard Medical School from 2008 to 2022.

<span class="mw-page-title-main">Ann Graybiel</span> American neuroscientist

Ann Martin Graybiel is an Institute Professor and a faculty member in the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology. She is also an investigator at the McGovern Institute for Brain Research. She is an expert on the basal ganglia and the neurophysiology of habit formation, implicit learning, and her work is relevant to Parkinson's disease, Huntington's disease, obsessive–compulsive disorder, substance abuse and other disorders that affect the basal ganglia.

Richard Lewis Huganir is a Bloomberg Distinguished Professor in the Departments of Neuroscience and Psychological and Brain Sciences, Director of the Solomon H. Snyder Department of Neuroscience, and co-director of the Johns Hopkins Medicine Brain Science Institute at the Johns Hopkins University School of Medicine. He has joint appointments in the Department of Biological Chemistry and the Department of Pharmacology and Molecular Sciences in the Johns Hopkins School of Medicine.

<span class="mw-page-title-main">Thomas C. Südhof</span> German-American biochemist

Thomas Christian Südhof, ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.

David Eidelberg is an American neuroscientist who is a professor of Neurology and Molecular Medicine at the Zucker School of Medicine. He is a neuroscientist best known for applying functional imaging of the brain to study neurological diseases.

<span class="mw-page-title-main">Michel Goedert</span> Luxembourgish-British neuroscientist

Michel Goedert FRS, FMedSci is a Luxembourgish-British neuroscientist and former Head of Neurobiology, at the MRC Laboratory of Molecular Biology.

<span class="mw-page-title-main">Max Planck Florida Institute for Neuroscience</span> Neuroscience institute in Jupiter, FL

The Max Planck Florida Institute for Neuroscience (MPFI), is a research facility located in Jupiter, Florida. Its research focuses on brain function and neural circuits, using techniques to visualize microscopic molecular processes. It is the first institute established by the Max Planck Society in North America.

James O. McNamara is an American neurologist and neuroscientist, known for his research of epileptogenesis, the process underlying development and progression of epilepsy. He is the Duke School of Medicine Professor of Neuroscience in the Departments of Neurobiology, Neurology, and Pharmacology and Cancer Biology at Duke University. He served as chair of the Department of Neurobiology at Duke from 2002 to 2011

Luis F. Parada is a Colombian developmental biologist and neuroscientist who currently serves as Director of the Brain Tumor Center, Albert C. Foster Chair and American Cancer Society Research Professor at Memorial Sloan Kettering Cancer Center in New York City, New York.

<span class="mw-page-title-main">Lim Kah Leong</span>

Lim Kah Leong, is a Singaporean neuroscientist and tenured full Professor and Associate Vice President for Research at the Nanyang Technological University (Singapore), where he is also a President's Chair Professor in Translational Neuroscience. He was previously the Vice Dean for Research at the Lee Kong Chian School of Medicine at NTU, Chair of the Department of Physiology at the National University of Singapore, Singapore and the deputy director for research at the National Neuroscience Institute, Singapore. Dr. Lim is known for his research in Parkinson's Disease. His research focuses on unraveling the molecular mechanisms underlying neurodegenerative diseases, with the view to develop novel therapies aimed at effectively treating the disease.

Liqun Luo is a neuroscientist in the Department of Biology at Stanford University, where he is the Ann and Bill Swindells Professor in the School of Humanities and Sciences, and an investigator of the Howard Hughes Medical Institute. His laboratory studies the development and organization of neural circuits, and he is the author of the textbook Principles of Neurobiology.

Jeffrey D. Macklis is an American neuroscientist. He is the Max and Anne Wien Professor of Life Sciences in the Department of Stem Cell and Regenerative Biology and Center for Brain Science at Harvard University, Professor of Neurology [Neuroscience] at Harvard Medical School, and on the Executive Committee and a Member of the Principal Faculty of the Neuroscience / Nervous System Diseases Program at the Harvard Stem Cell Institute.

HollisT. Cline is an American neuroscientist and the Director of the Dorris Neuroscience Center at the Scripps Research Institute in California. Her research focuses on the impact of sensory experience on brain development and plasticity.

Hilal Lashuel is an American-Yemeni neuroscientist and chemist, currently an associate professor at the EPFL. His research focuses on protein misfolding and aggregation in the pathogenesis of Alzheimer's and Parkinson's diseases.

<span class="mw-page-title-main">Elaine Hsiao</span> American biologist and academic

Elaine Yih-Nien Hsiao is an American biologist who is Professor in Biological Sciences at University of California, Los Angeles. Her research considers the microbes that impact human health. She was a 2022 Laureate for the Blavatnik Awards for Young Scientists.

References

  1. 1 2 "Scientific Advisory Board". Parkinson's Foundation . Retrieved 23 January 2023.
  2. ↑ "Richard J. Smeyne, PhD". Thomas Jefferson University . Retrieved 23 January 2023.
  3. ↑ "Parkinson's gene initiates disease outside of the brain". EurekAlert!. Retrieved 23 January 2023.
  4. ↑ "Richard Jay Smeyne, PhD". The Michael J. Fox Foundation . Retrieved 23 January 2023.
  5. ↑ "All the Right Moves". Thomas Jefferson University . Retrieved 23 January 2023.
  6. ↑ "Developmental Neurobiology".
  7. ↑ "Global Care Network | Parkinson's Foundation".
  8. ↑ Faherty, C. J.; Raviie Shepherd, K.; Herasimtschuk, A.; Smeyne, R. J. (2005). "Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism". Brain Research. Molecular Brain Research. 134 (1): 170–179. doi:10.1016/j.molbrainres.2004.08.008. PMID   15790541.
  9. ↑ "Scientific Advisory Board | Parkinson's Foundation".
  10. ↑ "World's Best Neuroscience Scientists: H-Index Neuroscience Science Ranking 2023 | Research.com".


Flag of the United States.svg Scientist.svg Science-symbol-2.svg

This article about an American scientist is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.